Mucolipidoses

The mucolipidoses are lysosomal storage disorders that combine mucopolysaccharide-like and lipid-storage features, but arise from lysosomal hydrolase trafficking, targeting, or endolysosomal membrane-transport defects rather than a single GAG-degrading enzyme deficiency. The current DisMech grouping spans GNPTAB/GNPTG GlcNAc-1-phosphotransferase defects and MCOLN1/TRPML1 channel dysfunction.

Shared Mechanism Shared Pathway

Why this grouping

Grouped as a mechanistic lysosomal-storage subgroup: members conform to the lysosomal_substrate_accumulation module but are distinguished from the mucopolysaccharidoses by failure of lysosomal hydrolase targeting/trafficking or endolysosomal ion-channel function rather than deficiency of one GAG-catabolic enzyme. They are kept as separate Disease entries because GNPTAB loss causes severe I-cell disease, GNPTG loss causes the attenuated mucolipidosis III gamma phenotype, and MCOLN1 loss causes mucolipidosis IV with prominent neurodevelopmental and ocular disease.

Membership criteria

NECESSARY  (member ⇒ criteria)
A member is a lysosomal storage disorder that conforms to the lysosomal substrate accumulation module and perturbs lysosomal hydrolase targeting, lysosomal transport, or autophagic-endolysosomal membrane function.

Coverage and gaps

4 rows Exact MONDO scope not assessed 4 listed with MONDO ID

No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.

Status DisMech entry MONDO concept In DisMech Has MONDO ID In grouping MONDO Member state Conditions satisfied C1.1 Conforms to the lysosomal substrate accumulation module. C1.2 Defective protein targeting to lysosome. GO:0006622 C1.3 Abnormal lysosomal transport. GO:0007041 C1.4 Abnormal autophagy. GO:0006914
listed with MONDO ID
GNPTG-Mucolipidosis DISEASE
Differentiating mechanism
GNPTG gamma-subunit deficiency attenuates GlcNAc-1-phosphotransferase function, producing a later-onset mucolipidosis III gamma phenotype with skeletal dysplasia, joint limitation, pain, and cardiac valve disease. GNPTG hgnc:23026
GNPTG-mucolipidosis
MONDO:0009652
yes yes not assessed listed satisfied SATISFIED SATISFIED SATISFIED NOT SATISFIED
listed with MONDO ID
Mucolipidosis Type II DISEASE
Differentiating mechanism
Severe GNPTAB-associated loss of GlcNAc-1-phosphotransferase abolishes mannose-6-phosphate tagging of soluble lysosomal hydrolases, causing missorting, hypersecretion, and multisubstrate lysosomal storage. GNPTAB hgnc:29670
mucolipidosis type II
MONDO:0009650
yes yes not assessed listed satisfied SATISFIED SATISFIED SATISFIED NOT SATISFIED
listed with MONDO ID
Mucolipidosis Type III Alpha/Beta DISEASE
Differentiating mechanism
Attenuated GNPTAB variants retain residual GlcNAc-1-phosphotransferase activity, so the same alpha/beta-subunit gene that causes mucolipidosis II instead produces a slowly progressive, later-onset disorder of skeletal dysplasia, joint stiffness and pain, cardiac valve disease, and only mild CNS involvement — the allelic-severity counterpart of ML II and the alpha/beta-subunit counterpart of GNPTG-mucolipidosis (ML III gamma). GNPTAB hgnc:29670
mucolipidosis type III, alpha/beta
MONDO:0018931
yes yes not assessed listed satisfied SATISFIED SATISFIED SATISFIED NOT SATISFIED
listed with MONDO ID
Mucolipidosis Type IV DISEASE
Differentiating mechanism
MCOLN1/TRPML1 loss disrupts endolysosomal calcium signaling, autophagy, and membrane trafficking, producing a neurodevelopmental and ocular mucolipidosis rather than a hydrolase-targeting defect. MCOLN1 hgnc:13356
mucolipidosis type IV
MONDO:0009653
yes yes not assessed listed satisfied SATISFIED NOT SATISFIED NOT SATISFIED SATISFIED

Source

View YAML on GitHub
Raw YAML
name: Mucolipidoses
display_name: Mucolipidoses
creation_date: "2026-06-18T00:00:00Z"
description: >-
  The mucolipidoses are lysosomal storage disorders that combine
  mucopolysaccharide-like and lipid-storage features, but arise from lysosomal
  hydrolase trafficking, targeting, or endolysosomal membrane-transport defects
  rather than a single GAG-degrading enzyme deficiency. The current DisMech
  grouping spans GNPTAB/GNPTG GlcNAc-1-phosphotransferase defects and
  MCOLN1/TRPML1 channel dysfunction.
grouping_basis:
- SHARED_MECHANISM
- SHARED_PATHWAY
grouping_rationale: >-
  Grouped as a mechanistic lysosomal-storage subgroup: members conform to the
  lysosomal_substrate_accumulation module but are distinguished from the
  mucopolysaccharidoses by failure of lysosomal hydrolase targeting/trafficking
  or endolysosomal ion-channel function rather than deficiency of one
  GAG-catabolic enzyme. They are kept as separate Disease entries because
  GNPTAB loss causes severe I-cell disease, GNPTG loss causes the attenuated
  mucolipidosis III gamma phenotype, and MCOLN1 loss causes mucolipidosis IV
  with prominent neurodevelopmental and ocular disease.
membership_criteria:
- description: >-
    A member is a lysosomal storage disorder that conforms to the lysosomal
    substrate accumulation module and perturbs lysosomal hydrolase targeting,
    lysosomal transport, or autophagic-endolysosomal membrane function.
  criteria_semantics: NECESSARY
  logic:
    operator: AND
    operands:
    - criterion_predicate: CONFORMS_TO_MODULE
      module: lysosomal_substrate_accumulation#Lysosomal Substrate Accumulation
      description: >-
        Conforms to the lysosomal substrate accumulation module.
    - operator: OR
      description: >-
        Perturbs hydrolase targeting, lysosomal transport, or autophagic
        endolysosomal membrane function.
      operands:
      - criterion_predicate: HAS_BIOLOGICAL_PROCESS
        description: Defective protein targeting to lysosome.
        biological_processes:
        - preferred_term: protein targeting to lysosome
          term:
            id: GO:0006622
            label: protein targeting to lysosome
          modifier: DECREASED
      - criterion_predicate: HAS_BIOLOGICAL_PROCESS
        description: Abnormal lysosomal transport.
        biological_processes:
        - preferred_term: lysosomal transport
          term:
            id: GO:0007041
            label: lysosomal transport
          modifier: ABNORMAL
      - criterion_predicate: HAS_BIOLOGICAL_PROCESS
        description: Abnormal autophagy.
        biological_processes:
        - preferred_term: autophagy
          term:
            id: GO:0006914
            label: autophagy
          modifier: ABNORMAL
members:
- member: Mucolipidosis Type II
  member_type: DISEASE
  display_name: Mucolipidosis type II (I-cell disease)
  differentiating_mechanisms:
  - description: >-
      Severe GNPTAB-associated loss of GlcNAc-1-phosphotransferase abolishes
      mannose-6-phosphate tagging of soluble lysosomal hydrolases, causing
      missorting, hypersecretion, and multisubstrate lysosomal storage.
    gene:
      preferred_term: GNPTAB
      term:
        id: hgnc:29670
        label: GNPTAB
- member: GNPTG-Mucolipidosis
  member_type: DISEASE
  display_name: Mucolipidosis III gamma
  differentiating_mechanisms:
  - description: >-
      GNPTG gamma-subunit deficiency attenuates GlcNAc-1-phosphotransferase
      function, producing a later-onset mucolipidosis III gamma phenotype with
      skeletal dysplasia, joint limitation, pain, and cardiac valve disease.
    gene:
      preferred_term: GNPTG
      term:
        id: hgnc:23026
        label: GNPTG
- member: Mucolipidosis Type IV
  member_type: DISEASE
  display_name: Mucolipidosis type IV
  differentiating_mechanisms:
  - description: >-
      MCOLN1/TRPML1 loss disrupts endolysosomal calcium signaling, autophagy,
      and membrane trafficking, producing a neurodevelopmental and ocular
      mucolipidosis rather than a hydrolase-targeting defect.
    gene:
      preferred_term: MCOLN1
      term:
        id: hgnc:13356
        label: MCOLN1
- member: Mucolipidosis Type III Alpha/Beta
  member_type: DISEASE
  display_name: Mucolipidosis III alpha/beta (pseudo-Hurler polydystrophy)
  differentiating_mechanisms:
  - description: >-
      Attenuated GNPTAB variants retain residual GlcNAc-1-phosphotransferase
      activity, so the same alpha/beta-subunit gene that causes mucolipidosis II
      instead produces a slowly progressive, later-onset disorder of skeletal
      dysplasia, joint stiffness and pain, cardiac valve disease, and only mild
      CNS involvement — the allelic-severity counterpart of ML II and the
      alpha/beta-subunit counterpart of GNPTG-mucolipidosis (ML III gamma).
    gene:
      preferred_term: GNPTAB
      term:
        id: hgnc:29670
        label: GNPTAB
notes: >-
  Nested LSD subgroup. It should be represented as a GROUPING member of
  Lysosomal Storage Disorders rather than mixing its individual members at the
  parent LSD level.